BBCBBC·4hHealth
score-0.65
FDA Panel Opens Pathway for Expanded Research Into Peptides, Drawing Calls for Rigorous Human Safety Studies
Original
FDA panel loosens restrictions for controversial peptides popular online
“Uses 'controversial' and 'haven't been well studied' to emphasize safety concerns while framing FDA decision as political rather than evidence-based.”